DAX25.261 +0,9%Est506.131 +1,2%MSCI World4.343 -0,1%Top 10 Crypto8,6300 +1,3%Nas22.837 +0,7%Bitcoin57.335 +0,8%Euro1,1758 -0,1%Öl71,63 -0,4%Gold5.072 +1,5%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Rheinmetall 703000 Bayer BAY001 SAP 716460 NVIDIA 918422 Siemens Energy ENER6Y Deutsche Telekom 555750 Infineon 623100 Amazon 906866 Lufthansa 823212 Microsoft 870747 Airbus 938914 RENK RENK73 BASF BASF11 Siemens 723610 DroneShield A2DMAA
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
DAX geht stärker ins Wochenende -- Supreme Court stoppt Trump-Zölle -- NVIDIA wohl mit Milliardeninvestment in OpenAI -- Apple, Telekom, BioNTech, Moderna, Diginex, Bayer, im Fokus
Top News
Portfolio-Update: Mutares - Ruhe vor dem Sturm Portfolio-Update: Mutares - Ruhe vor dem Sturm
Infineon-Aktie heute Ex-Dividende: Bullishe Signale durch KI-Fokus Infineon-Aktie heute Ex-Dividende: Bullishe Signale durch KI-Fokus
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

Bio-Techne Aktie

Kaufen
Verkaufen
Bio-Techne Aktien-Sparplan
48,20 EUR -1,20 EUR -2,43 %
STU
57,06 USD -1,18 USD -2,03 %
BTT
Bio-Techne jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

Marktkap.7,89 Mrd. EUR

KGV112,02Div. Rendite0,62%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKNA12ENG

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS09073M1045

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolTECH

Bio-Techne Aktien News

DatumMeistgelesen
PR NewswireBIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH THERMO FISHER SCIENTIFIC
PR NewswireBIO-TECHNE AND NOVOMOL-Dx ANNOUNCE POINT-OF-CARE OCULAR BIOMARKER ASSAY
PR NewswireEvolve Announces April 2024 Distributions for Certain Evolve Funds
PR NewswireBIO-TECHNE TO HOST CONFERENCE CALL ON MAY 1, 2024, TO ANNOUNCE THIRD QUARTER FISCAL 2024 FINANCIAL RESULTS
PR NewswireBIO-TECHNE SURPASSES 10,000 PEER-REVIEWED PUBLICATIONS CITING RNAscope TECHNOLOGY
PR NewswireBIO-TECHNE TO PRESENT AT THE 2024 AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR) CONFERENCE
PR NewswireBIO-TECHNE RECEIVES CiteAb'S ELISA KIT SUPPLIER OF THE YEAR AND SPATIAL BIOLOGY INNOVATION AWARDS
PR NewswireBIO-TECHNE AND NIKON INSTRUMENTS INC. ANNOUNCE PARTNERSHIP TO EXPAND ACCESS TO INNOVATIVE SPATIAL BIOLOGY SERVICES
PR NewswireBIO-TECHNE RECEIVES EUROPEAN IVDR CERTIFICATION FOR DIAGNOSTIC TEST TO MONITOR CHRONIC MYELOID LEUKEMIA
PR NewswireEvolve Announces March 2024 Distributions for Certain Evolve Funds
PR NewswireBIO-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH INVESTOR FORUM
PR NewswireBIO-TECHNE TO PRESENT AT THE BARCLAYS 26th ANNUAL GLOBAL HEALTHCARE CONFERENCE
PR NewswireEvolve Announces February 2024 Distributions for Certain Evolve Funds
PR NewswireBIO-TECHNE DECLARES DIVIDEND
PR NewswireBIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
PR NewswireBIO-TECHNE'S ADVANCED CELL DIAGNOSTICS (ACD) SETS NEW STANDARD IN SPATIAL BIOLOGY WITH PROTEASE-FREE RNASCOPE MULTIOMICS
PR NewswireLUNAPHORE AND ACD REVOLUTIONIZE SPATIAL BIOLOGY RESEARCH WITH THE LAUNCH OF THE FIRST FULLY AUTOMATED, SAME-SECTION, HYPERPLEX MULTIOMICS APPLICATION
PR NewswireSCIENTISTS AT THE WCBP CONFERENCE HIGHLIGHT ADVANCEMENTS IN PROTEIN BIOTHERAPEUTIC CHARGE HETEROGENEITY CHARACTERIZATION USING THE MauriceFlex™ SYSTEM
PR NewswireEvolve Announces January 2024 Distributions for Certain Evolve Funds
PR NewswireBIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2024, TO ANNOUNCE SECOND QUARTER FISCAL 2024 FINANCIAL RESULTS
PR NewswireBIO-TECHNE ANNOUNCES APPOINTMENT OF MATTHEW F. McMANUS AS PRESIDENT, DIAGNOSTICS AND GENOMICS SEGMENT
PR NewswireBIO-TECHNE TO SHOWCASE CELL AND GENE THERAPY MANUFACTURING TOOLS AT PHACILITATE ADVANCED THERAPIES WEEK 2024
PR NewswireEvolve Announces Final 2023 Annual Distributions for Certain Evolve Funds
PR NewswireBIO-TECHNE TO PRESENT AT THE 42nd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
PR NewswireBIO-TECHNE ANNOUNCES SUBMISSION OF FDA DRUG MASTER FILE FOR EXCELLERATE GMP IPSC EXPANSION MEDIUM SUPPORTING STEM CELL THERAPY
PR NewswireEvolve Announces December 2023 Distributions for Certain Evolve Funds
PR NewswireLUNAPHORE AND SIB AWARDED INNOSUISSE FUNDING TO DEVELOP INNOVATIVE AI-BASED ASSAY DEVELOPMENT TOOLS
PR NewswireEvolve Announces Estimated Annual Distributions for Certain Evolve Funds
PR NewswireBIO-TECHNE TO PRESENT AT THE 6TH ANNUAL EVERCORE ISI HEALTHCONx CONFERENCE
PR NewswireBIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES
PR NewswireASURAGEN TO PRESENT NOVEL CLINICAL TESTING DATA AT AMP 2023 CONFERENCE
PR NewswireBIO-TECHNE DECLARES DIVIDEND
PR NewswireBIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
PR NewswireLEADING RESEARCH INSTITUTES TO PRESENT NEW DATA USING LUNAPHORE'S COMET™ TECHNOLOGY AT THE SOCIETY FOR IMMUNOTHERAPY OF CANCER (SITC) 38th ANNUAL MEETING
PR NewswireEvolve Announces October 2023 Distributions for Certain Evolve Funds
PR NewswireBIO-TECHNE APPOINTS KIM KELDERMAN AS CHIEF EXECUTIVE OFFICER
PR NewswireBIO-TECHNE ACHIEVES ISO 13485 CERTIFICATION FOR ITS WALLINGFORD, CT MANUFACTURING FACILITY
PR NewswireBIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 31, 2023, TO ANNOUNCE FIRST QUARTER FISCAL 2024 FINANCIAL RESULTS
PR NewswireDR. JORDAN LASER AWARDED AMP MERITORIOUS SERVICE AWARD
PR NewswireSCIENTISTS AT CE PHARM CONFERENCE DESCRIBE HOW Maurice™ AND MauriceFlex™ SYSTEMS TRANSFORM THEIR PROTEIN ANALYSIS

Bio-Techne News

Bio-Techne News: auf dieser Seite finden Sie alle Bio-Techne News und Nachrichten zur Bio-Techne Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Bio-Techne News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Bio-Techne News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.